Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies. - Falchook, G.; Duvic, M.; Hong, D.; Wheler, J.; Naing, A.; Lim, J.; Kurzrock, R. (Cancer Chemotherapy & Pharmacology, 2012)